|
1
|
Herszényi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.
|
|
2
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
3
|
Arkenau HT: Gastric cancer in the era of
molecularly targeted agents: current drug development strategies. J
Cancer Res Clin Oncol. 135:855–866. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yasui W, Sentani K, Motoshita J, et al:
Molecular pathobiology of gastric cancer. Scand J Surg. 95:225–231.
2006.
|
|
5
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang JF and Dai DQ: Metastatic suppressor
genes inactivated by aberrant methylation in gastric cancer. World
J Gastroenterol. 13:5692–5698. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Machado JC, Oliveira C, Carvalho R, et al:
E-cadherin gene (CDH1) promoter methylation as the second hit in
sporadic diffuse gastric carcinoma. Oncology. 20:1525–1528.
2001.PubMed/NCBI
|
|
8
|
Esteller M, Corn PG, Baylin SB, et al: A
gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
9
|
Buffart TE, Overmeer RM, Steenbergen RD,
et al: MAL promoter hypermethylation as a novel prognostic marker
in gastric cancer. Br J Cancer. 99:1802–1807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishikawa Y, Miyazaki T, Nakashiro K, et
al: Human FAT1 cadherin controls cell migration and invasion of
oral squamous cell carcinoma through the localization of β-catenin.
Oncol Rep. 26:587–592. 2011.PubMed/NCBI
|
|
11
|
Gumbiner BM: Regulation of
cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol.
6:622–634. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Batlle E, Sancho E, Franci C, et al: The
transcription factor snail is a repressor of E-cadherin gene
expression in epithelial tumour cells. Nat Cell Biol. 2:84–89.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Imoto I, Izumi H, Yokoi S, Hosoda H, et
al: Frequent silencing of the candidate tumor suppressor PCDH20 by
epigenetic mechanism in non-small-cell lung cancers. Cancer Res.
66:4617–4626. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ying J, Li H, Seng TJ, Langford C, et al:
Functional epigenetics identifies a protocadherin PCDH10 as a
candidate tumor suppressor for nasopharyngeal, esophagealand
multiple other carcinomas with frequent methylation. Oncogene.
25:1070–1080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haruki S, Imoto I, Kozaki K, et al:
Frequent silencing of protocadherin 17, a candidate tumour
suppressor for esophageal squamous-cell carcinoma. Carcinogenesis.
31:1027–1036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Strehl S, Glatt K, Liu QM, et al:
Characterization of two novel protocadherins (PCDH8 and PCDH9)
localized on human chromosome 13 and mouse chromosome 14. Gemomics.
53:81–89. 1998.PubMed/NCBI
|
|
17
|
Yu JS, Koujak S, Nagase S, et al: PCDH8,
the human homolog of PAPC, is a candidate tumor suppressor of
breast cancer. Oncogene. 27:4657–4665. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Herman JG, Graff JR, Myöhänen S, et al:
Methylation-specific PCR: a novel PCR assay for methylation status
of CpG islands. Proc Natl Acad Sci USA. 93:9821–9826. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gorringe KL, Ramakrishna M, Williams LH,
et al: Are there any more ovarian tumor suppressor genes? A new
perspective using ultra high-resolution copy number and loss of
heterozygosity analysis. Genes Chromosomes Cancer. 48:931–942.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Franko J, Krasinskas AM, Nikiforova MN, et
al: Loss of heterozygosity predicts poor survival after resection
of pancreatic adenocarcinoma. J Gastrointest Surg. 12:1664–1672.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang YC, Yeh KT, Liu TC, et al: Molecular
cytogenetic characterization of esophageal cancer detected by
comparative genomic hybridization. J Clin Lab Anal. 24:167–174.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ye Y, McDevitt MA, Guo M, et al:
Progressive chromatin repression and promoter methylation of CTNNA1
associated with advanced myeloid malignancies. Cancer Res.
69:8482–8490. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hukriede NA, Tsang TE, Habas R, et al:
Conserved requirement of Lim1 function for cell movements during
gastrulation. Dev Cell. 4:83–94. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Medina A, Swain RK, Kuerner KM and
Steinbeisser H: Xenopus paraxial protocadherin has signaling
functions and is involved in tissue separation. EMBO J.
23:3249–3258. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Unterseher F, Hefele JA, Giehl K, et al:
Paraxial protocadherin coordinates cell polarity during convergent
extension via Rho A and JNK. EMBO J. 23:3259–3269. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tian K, Jurukovski V, Wang XP, et al:
Epigenetic regulation of WTH3 in primary and cultured drugresistant
breast cancer cells. Cancer Res. 65:10024–10031. 2005. View Article : Google Scholar : PubMed/NCBI
|
